Without FDA approval or certifications like GMP (Good Manufacturing Practice), you cannot be sure of what is really inside each capsule
NICE (UK) positive for Zepbound (tirzepatide) for managing overweight and obesity Eli Lilly NICE (UK): 1.1 Tirzepatide is recommended as an option for managing overweight and obesity, alongside a reduced-calorie diet and increased physical activity in adults, only if they have: i) an initial body mass index (BMI) of at least 35 kg/m2 and ii) at least 1 weight-related comorbidity
This is very important to me
The dose and frequency (usually once a week) are decided by your doctor, depending on the individual health condition and tolerance to the treatment
In an email to Healio | Endocrine Today, an Eli Lilly spokesperson cited the FDAs warning letters to compounding pharmacies and published research showing impurities in some off-brand versions of GLP-1s
While oral medications exist, many patients find that injectable forms deliver more consistent results